Topotecan and Melphalan for Retinoblastoma

NCT04799002 · clinicaltrials.gov ↗

PHASE3

Phase

RECRUITING

Status

50

Enrollment

OTHER

Sponsor class

Conditions

Retinoblastoma
Chemotherapy Effect

Interventions

DRUG: Topotecan
DRUG: Melphalan

Sponsor

Sun Yat-sen University